help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carlsson, L. M.
Right arrow Articles by Merimee, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carlsson, L. M.
Right arrow Articles by Merimee, T. J.

Journal of Clinical Endocrinology & Metabolism, Vol 78, 1325-1330, Copyright © 1994 by Endocrine Society


ARTICLES

Reduced concentration of serum growth hormone-binding protein in children with idiopathic short stature. National Cooperative Growth Study

LM Carlsson, KM Attie, PG Compton, RV Vitangcol and TJ Merimee
Genetech, Inc., South San Francisco, California 94080.

One possible explanation for the growth failure in children with idiopathic short stature (ISS) is reduced peripheral responsiveness to GH. In Laron syndrome, growth retardation is caused by GH resistance due to GH receptor (GH-R) defects, which are associated in most cases with absent or low serum concentrations of the GH-R-related GH-binding protein (GHBP). We tested the hypothesis that some children with ISS have reduced serum concentrations of GHBP and that this may reflect decreased sensitivity to GH. A ligand-mediated immunofunctional assay was used to measure biochemically active GHBP in serum from 1549 children, including 773 controls, 573 with ISS, 107 with GH deficiency (GHD), and 96 with Turner syndrome (TS). Ages ranged from 1-17 yr. Serum GHBP concentrations in children with GHD, ISS, and TS were converted to SD scores and compared to controls by analysis of variance. In male and female ISS subjects, approximately 90% had GHBP concentrations below the age- and sex-adjusted mean for controls, and 20% had GHBP concentrations below the normal range. The mean serum GHBP SD score was lower in both males and females with GHD (-0.6) or ISS (- 1.2) than in controls (both P < 0.005). The mean for ISS males was significantly lower than that for GHD males (P < 0.0001). The mean GHBP SD score for girls with TS (-0.3) did not differ significantly from that of the control females. The decreased levels of serum GHBP in some children with idiopathic short stature suggest that these children could have a defect at the level of the GH-R.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
C. K. Buckway, K. A. Selva, K. L. Pratt, E. Tjoeng, J. Guevara-Aguirre, and R. G. Rosenfeld
Insulin-Like Growth Factor Binding Protein-3 Generation as a Measure of GH Sensitivity
J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4754 - 4765.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. M. Wit and L. T. M. Rekers-Mombarg
Final Height Gain by GH Therapy in Children with Idiopathic Short Stature Is Dose Dependent
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 604 - 611.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. K. Buckway, J. Guevara-Aguirre, K. L. Pratt, C. P. Burren, and R. G. Rosenfeld
The IGF-I Generation Test Revisited: A Marker of GH Sensitivity
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5176 - 5183.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Sjoberg, T. Salazar, C. Espinosa, A. Dagnino, A. Avila, M. Eggers, F. Cassorla, P. Carvallo, and M. V. Mericq
Study of GH Sensitivity in Chilean Patients with Idiopathic Short Stature
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4375 - 4381.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Tonshoff, M. J. Cronin, M. Reichert, D. Haffner, A.-M. Wingen, W. F. Blum, and O. Mehls
Reduced Concentration of Serum Growth Hormone (GH)-Binding Protein in Children with Chronic Renal Failure: Correlation with GH Insensitivity
J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1007 - 1013.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Boguszewski, R. Bjarnason, S. Rosberg, L. M. S. Carlsson, and K. Albertsson-Wikland
Growth Hormone (GH)-Binding Protein in Prepubertal Short Children Born Small for Gestational Age: Effects of Growth Hormone Treatment
J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1014 - 1019.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Fisker, N. Vahl, J. O. L. Jorgensen, J. S. Christiansen, and H. Orskov
Abdominal Fat Determines Growth Hormone-Binding Protein Levels in Healthy Nonobese Adults
J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 123 - 128.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. D. Goddard, R. Covello, S.-M. Luoh, T. Clackson, K. M. Attie, N. Gesundheit, A. C. Rundle, J. A. Wells, L. M.S. Carlsson, and The Growth Hormone Insensitivity Study Group
Mutations of the Growth Hormone Receptor in Children with Idiopathic Short Stature
N. Engl. J. Med., October 26, 1995; 333(17): 1093 - 1098.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society